Surgery Partners, Inc. (SGRY) stock forecast & analysis
23.21
NasdaqGS · USDDelayed by 15 minutes
Unchanged: +0.00, +0.0%
23.21Unchanged: +0.00, +0.0%
1 analysis
Latest analysis: · verdict locked
- Open
- 23.24
- Previous close
- 23.21
- Day range
- 23.19 – 23.25
- 52-week range
- 11.41 – 23.37
- Volume (shares)
- 3.39M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 128.87M
- P/E ratio
- Not available
- Dividend yield
- 0.00%
- Beta
- 1.91
- Market cap
- 2.99B
Market Scanner’s AI analysis of Surgery Partners, Inc. (SGRY), updated October 2026: Surgery Partners (SGRY) saw significant price surges and technical strength amid news of a potential take-private deal.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of Surgery Partners, Inc. (SGRY) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
Surgery Partners (SGRY) saw significant price surges and technical strength amid news of a potential take-private deal.
Recent analyses for Surgery Partners (SGRY) covered a substantial price increase driven by a potential take-private transaction. The market analyst report noted strong upward momentum with key technical indicators such as SMAs, EMAs, RSI, and MACD all signaling positive trends, despite the RSI indicating overbought conditions. The fundamentals analyst report detailed the company's financial standing within the Medical Care Facilities industry, highlighting revenue, profitability, and debt levels.
SGRY news & sentiment
News reports highlighted significant stock volatility surrounding a potential take-private deal, with some suggesting the offer might exceed fair value while others indicated the stock was overvalued. Social media sentiment appeared positive, aligning with broader market optimism that lifted tech stocks.
SGRY technical picture
SGRY's price action showed significant upward momentum, trading well above its 50-day and 200-day SMAs. Momentum indicators like the RSI and MFI suggested strong buying pressure, though the RSI indicated overbought conditions. The price was also above the upper Bollinger Band, pointing to strong upward price action.
Fundamentals
Surgery Partners (SGRY) reported modest year-over-year quarterly revenue growth. The company's profitability metrics showed a negative profit margin and consistent annual net losses, alongside a negative return on equity. Significant total debt was noted relative to available cash.
Factors discussed — upside
- Strong upward price momentum indicated by SMAs and EMAs.
- Positive MACD value suggesting momentum.
- High MFI indicating strong buying pressure.
- Significant short-term price appreciation (7-day and 30-day changes).
- Potential take-private deal driving stock surge.
Factors discussed — risks
- RSI in overbought territory.
- Price above upper Bollinger Band suggesting potential pullback.
- Negative profit margin (-2.6%).
- Consistent annual net losses over the past four years.
- High total debt relative to cash.
- Take-private deal speculation
- Technical indicators
- Financial performance
- Market sentiment
Summary updated .
SGRY technical indicators
Common technical indicators for SGRY, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 15.13 | Price above |
| 10-day exponential moving average | 20.26 | Price above |
| Relative strength index (14-day) | 86.16 | Overbought |
| MACD line (12/26/9) | 2.2989 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 9.06 – 24.39 | Price inside the bands |
Analyses
Recent SGRY.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-10-27 SGRY.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for Surgery Partners, Inc.?
- The bull case for Surgery Partners (SGRY) centers on a potential take-private deal that has driven a significant stock surge. This upward momentum is supported by strong technical indicators, including positive trends in SMAs, EMAs, and MACD, alongside high Money Flow Index readings indicating robust buying pressure.
- What are the risks for Surgery Partners, Inc.?
- Risks for Surgery Partners (SGRY) include technical indicators showing the stock is in overbought territory and trading above its upper Bollinger Band, suggesting a potential pullback. Financially, the company has a negative profit margin, has reported annual net losses for the past four years, and carries a substantial amount of debt relative to its cash reserves.
- Is Surgery Partners, Inc. bullish or bearish?
- Recent AI analyses of Surgery Partners, Inc. examined factors on both sides. Discussed upside: The bull case for Surgery Partners (SGRY) centers on a potential take-private deal that has driven a significant stock surge. This upward momentum is supported by strong technical indicators, including positive trends in SMAs, EMAs, and MACD, alongside high Money Flow Index readings indicating robust buying pressure. Discussed risks: Risks for Surgery Partners (SGRY) include technical indicators showing the stock is in overbought territory and trading above its upper Bollinger Band, suggesting a potential pullback. Financially, the company has a negative profit margin, has reported annual net losses for the past four years, and carries a substantial amount of debt relative to its cash reserves. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Surgery Partners, Inc.?
- News reports highlighted significant stock volatility surrounding a potential take-private deal, with some suggesting the offer might exceed fair value while others indicated the stock was overvalued. Social media sentiment appeared positive, aligning with broader market optimism that lifted tech stocks.
- How does Market Scanner analyse Surgery Partners, Inc.?
- Every analysis of Surgery Partners, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for Surgery Partners, Inc.?
The bull case for Surgery Partners (SGRY) centers on a potential take-private deal that has driven a significant stock surge. This upward momentum is supported by strong technical indicators, including positive trends in SMAs, EMAs, and MACD, alongside high Money Flow Index readings indicating robust buying pressure.
What are the risks for Surgery Partners, Inc.?
Risks for Surgery Partners (SGRY) include technical indicators showing the stock is in overbought territory and trading above its upper Bollinger Band, suggesting a potential pullback. Financially, the company has a negative profit margin, has reported annual net losses for the past four years, and carries a substantial amount of debt relative to its cash reserves.
Is Surgery Partners, Inc. bullish or bearish?
Recent AI analyses of Surgery Partners, Inc. examined factors on both sides. Discussed upside: The bull case for Surgery Partners (SGRY) centers on a potential take-private deal that has driven a significant stock surge. This upward momentum is supported by strong technical indicators, including positive trends in SMAs, EMAs, and MACD, alongside high Money Flow Index readings indicating robust buying pressure. Discussed risks: Risks for Surgery Partners (SGRY) include technical indicators showing the stock is in overbought territory and trading above its upper Bollinger Band, suggesting a potential pullback. Financially, the company has a negative profit margin, has reported annual net losses for the past four years, and carries a substantial amount of debt relative to its cash reserves. These are descriptive observations, not a recommendation.
What is the latest sentiment on Surgery Partners, Inc.?
News reports highlighted significant stock volatility surrounding a potential take-private deal, with some suggesting the offer might exceed fair value while others indicated the stock was overvalued. Social media sentiment appeared positive, aligning with broader market optimism that lifted tech stocks.
How does Market Scanner analyse Surgery Partners, Inc.?
Every analysis of Surgery Partners, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh SGRY.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.